SHL - Sonic Healthcare

 SHL Sonic Healthcare

02/07/26

https://investors.sonichealthcare.com/Investors/

..............................

ASX:SHL (Sonic Healthcare) has experienced a steady normalization of earnings over the last 5 years as the massive COVID-19 testing boom receded. While revenues have been supported by acquisitions, statutory net profit has declined from a peak of approx $1.46B in FY2022 to about $514M in FY2025. [1, 2, 3, 4, 5]

Financial Snapshot

• Profit: Net profit dropped from its pandemic peak to roughly $513.6M for FY2025. In the 12 months leading into 2026, the company generated revenues of $10.42B with annualized profits of about $539M. [1, 2, 3]

• Debt: The company maintains a conservative balance sheet. As of recent 2026 periods, long-term debt sits near $3.87B (net debt), representing a manageable Debt/Equity ratio of approximately 56% to 68%. Interest coverage remains solid at around 5 to 10 times. [1, 2, 3, 4]
• ROE: Return on Equity (ROE) has compressed to the 6% - 7% range as equity expanded and pandemic-era margins (which previously exceeded 15% normalized down to around 5.2%. [1, 2, 3]

..............................